

Can't find Fluticasone/Salmeterol? Here are the best alternatives to Advair, including Symbicort, Breo Ellipta, and Dulera, with details on each.
If you've been searching for Fluticasone/Salmeterol — whether it's Advair Diskus, Wixela Inhub, or AirDuo RespiClick — and your pharmacy keeps coming up empty, you're not alone. Supply disruptions have made this common inhaler difficult to find in 2026.
The good news is that several other inhalers work similarly. In this post, we'll explain what Fluticasone/Salmeterol does, how it works, and walk through the best alternatives your doctor might recommend.
Important: Never switch medications on your own. Always talk to your doctor or prescriber before changing inhalers. Different devices, doses, and drug combinations require medical guidance.
Fluticasone/Salmeterol is a combination inhaler that contains two types of medication:
It's prescribed for asthma maintenance and COPD management. You take it twice daily — it's not a rescue inhaler. For a full overview, see our guide on what Fluticasone/Salmeterol is and how to use it.
The two ingredients in Fluticasone/Salmeterol tackle breathing problems from two different angles:
Fluticasone works by calming down the inflammatory response in your lungs. When you have asthma or COPD, your airways become inflamed, swollen, and produce extra mucus. Fluticasone reduces this inflammation over time, making your airways less sensitive to triggers like allergens, cold air, or exercise.
Salmeterol works by binding to beta-2 receptors on the smooth muscle surrounding your airways. This causes the muscles to relax and the airways to widen (bronchodilation). Because it's "long-acting," this effect lasts about 12 hours — which is why you take it twice a day.
Together, these two medications provide both anti-inflammatory control and bronchodilation. This is the standard approach for patients whose asthma or COPD isn't well controlled with an inhaled corticosteroid alone. For more detail, read our post on how Fluticasone/Salmeterol works.
All of the alternatives below are also ICS/LABA combination inhalers. They work on the same principle — combining an anti-inflammatory corticosteroid with a long-acting bronchodilator. However, they use different specific drugs, different inhaler devices, and sometimes different dosing schedules.
Symbicort is one of the most commonly prescribed alternatives to Advair. It's a metered-dose inhaler (MDI) that combines Budesonide (an ICS) with Formoterol (a LABA).
Breo Ellipta is a once-daily dry powder inhaler made by GSK — the same company that makes Advair.
Dulera is a metered-dose inhaler that combines Mometasone (an ICS) with Formoterol (a LABA).
Trelegy Ellipta is a step up — it's a triple therapy inhaler that adds a long-acting muscarinic antagonist (LAMA) to the ICS/LABA combination.
If you can't find Fluticasone/Salmeterol, bring these alternatives up with your doctor. Here's what to discuss:
Switching medications isn't always necessary. Before making a change, use Medfinder to see if any pharmacy near you has Fluticasone/Salmeterol in stock. You might also ask about different formulations — if Advair Diskus is out, Wixela Inhub or AirDuo RespiClick might be available. Check our tips on finding Fluticasone/Salmeterol in stock.
Not being able to find your inhaler is stressful, but you have options. Symbicort, Breo Ellipta, Dulera, and Trelegy Ellipta all work on similar principles and can be effective alternatives to Fluticasone/Salmeterol. The key is to work with your doctor to find the right fit for your lungs, your lifestyle, and your budget.
And remember — before switching, check Medfinder to see if your current medication is available somewhere nearby. Sometimes the solution is as simple as trying a different pharmacy.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.